Rein Therapeutics Inc.
XNAS: RNTX
Rein Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart
about
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LT...
Read More
1.27
0.02
(1.60%)
34,147
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Rein Therapeutics Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..